Axonics Inc (NAS:AXNX)
$ 67.22 -0.11 (-0.16%) Market Cap: 3.43 Bil Enterprise Value: 3.13 Bil PE Ratio: 0 PB Ratio: 5.47 GF Score: 83/100

Axonics Modulation Technologies Inc at Barclays Global Healthcare Conference Transcript

Mar 14, 2019 / 01:30PM GMT
Release Date Price: $21.5 (-2.27%)
Kristen Marie Stewart
Barclays Bank PLC, Research Division - Research Analyst

Joining us here for the next session at the Barclays Global Healthcare Conference. I'm Kristen Stewart, the medical supplies and device analyst. It is my pleasure to have Axonics here to talk about their technology and their program, their recent IPO in the MedTech space. So a newer entry here into the public domain. With us we have Dan Dearen, the company's CFO. We did have a little bit of a schedule change as Ray was unavailable. So Ray, we miss you, hope you're doing well. But Dan, without further ado, I'll turn it over to you.

Danny L. Dearen
Axonics Modulation Technologies, Inc. - President & CFO

Thank you very much. Thank you for having us. Thanks to Barclays, we have a long-standing relationship with the firm. As she mentioned, I'm Dan Dearen, I'm the President, Cofounder and Chief Financial Officer of the company, and Ray sends his regards. It's a pleasure to be here today to talk to you about Axonics and our neuromodulation system to treat chronic overactive bladder.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot